Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Jul 5, 2022
Document Date
Jul 5, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Aclaris Therapeutics, Inc.
Issuer
Aclaris Therapeutics, Inc.
Filer
Cawkwell Gail